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Mycoplasma neurolyticum was identified  as the cause of "rolling disease" in mice by 
Sabin (1) and Findlay et al. (2) in 1938. These investigators encountered the agent in 
the course of intracerebral passages of mouse brain homogenates in mice. The neuro- 
logical syndrome was bizarre and unique, characterized by the abrupt onset of con- 
tinual rolling  movements to one side  or the other, persisting for several hours and 
terminating in generalized  convulsive  seizures  and death.  Rolling was produced by 
intmvenons injections of broth cultures of the mycoplasma, and culture filtrates were 
shown to contain a thermolabile exotoxin with the same property (3). Histologic study 
of the brains of mice surviving for 18 hr revealed axeas of cystic degeneration in the 
cerebeUax poles, which were considered  to be the basis for the neurologic manifesta- 
tions.  Recently, Tully (4)  succeeded  in cultivating Sabin's original  strain of myco- 
pl~sma (designated  strain A)  from lyophili~ed  samples stored since  1943, and reex- 
amined its properties. In confirmation of Sabin's observations, he noted that the exo- 
toxin was readily obtained in broth filtrates of young cultures, but disappeared from 
cultures incubated 48 hr or longer; the washed organisms elicited the same neurologic 
syndrome as theexotoxin; young mice and rats were much more susceptible  than ma- 
ture animals; the toxicity of both exotoxin and suspensions of whole mycoplasmas was 
eliminated by heating at relatively low temperatures. 
The present study is concerned with these and other properties of M. neuroly- 
ticum,  in mice and rats.  It will be shown that the  exotoxin becomes fixed to 
tissue  receptors  within  a  few minutes  after  injection;  rapid  inactivation  by 
binding  to  a  sedimentable component of rat brain  is demonstrable  in vitro; 
evidence  will  be  presented  indicating  that  this  inactivation  is  mediated  by 
brain ganglioside. Neuropathologic studies of the brain lesions suggest that the 
action of toxin is primarily directed against membranes regulating the perme- 
ability of the brain to fluid. 
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Material and Methods 
Strains A and KSA of M. ~urolyticum were supplied by Dr. Joseph Tully, of the National 
Institutes of Health. Strain A was received as the 21st passage in Difco serum fraction PPLO 
broth; after several passages in this laboratory, in PPLO broth as modified by Chanock, Hay- 
flick, and Baffle (5). Several liters representing the 30th through 33rd passage were distributed 
in 10-ml aliquots and stored frozen at --70°C. Subcultures of these were used for all experi- 
ments to be described. This procedure was used because of earlier observations indicating loss 
of toxicity  after numerous subcultures of this organism. The KSA strain was the 147th passage 
when received, and produced no demonstrable toxin; this strain was employed for antibody 
protection experiments to be described below. 
Crude preparations of exotoxin were made by inoculating PPLO broth with a 3% inoculum 
of frozen stock culture, incubating 18 hr or until turbid growth appeared, then making a new 
2% inoculum from this and incubating approximately  20 hr. Empirically,  it appeared that the 
most active toxins were obtained from cultures in which the pH had dropped to 7.0 to 6.8 at 
the time of harvesting. The broth was centrifuged at 13,000 g for 30 rain, at 4°C, and the 
supemate decanted. Mice weighing 10 to 12 g were injected with 0.5 ml of this material, by 
tail vein. For titrafions of toxin, dilutions were made in Ringer's solution. Rats, weighing 150 
to 200 g, were injected with 2 ml of toxin by tail vein. The toxin remained active after lyo- 
philizafion, and most of the studies reported below were performed with lyophilized stocks 
of known potency. 
Anfi-mycoplasma antibody was prepared in rabbits by injecting a suspension  of 10-fold 
concentrated mycoplasmas,  incorporated in Freund's adjuvant, subcutaneously. Antisera for 
protection experiments were obtained 2 wk after the 4th weekly injection of antigen. The 
presence and specificity  of antibody was determined by Clyde's growth-inhibition method (6). 
RESULTS 
Description of Rolling Disease 
The onset of neurologic signs usually occurred between 30 and 60 min after 
intravenous injection of the toxin derived from whole broth. The earliest signs 
were spasmodic hyperextension of the head and raising of one forepaw, followed 
within  a  few minutes  by the beginning of roiling. The  animals rolled on  the 
long  axis  of  the  body,  intermittently  at  first  and  then  continually,  with 
occasional intervening periods in which  they leaped  or ran rapidly about the 
cage.  Rolling persisted for  1  or 2  hr,  after which  they became  immobile and 
comatose.  Some died in this condition, while others  developed  repeated con- 
vulsive seizures,  with  rigid hyperextension of the hind limbs terminally,  and 
then died. Most of the mice died within less than 4 hr after the onset of rolling, 
but approximately 5 %  of each group survived in a  comatose condition for 1 or 
2 days. 
The time of onset of the syndrome, and the time fo death, were closely related 
to the dose of toxin administered (Table I). With concentrated toxin, prepared 
by reconstituting  lyophilized toxin in  distilled water  half  the  volume  of  the 
original broth, rolling began within 5 to 10 min and death occurred in less than 
30  min.  Some  of  these  animals  developed  acute  plllmonary  edema  simul- 
taneously with rolling, and died with bloody froth at their nostrils within the 
next minute or so. With smaller doses, representing dilutions of 1 to 8 or 1 to 16 THOMAS~ ALEU,  BITENSKY~  DAVIDSON,  AND  GESNER  1069 
of the original broth, the onset of rolling was usually delayed for as long as 2 hr, 
with death several hours later. 
The end point in  fitrations of toxin was always very sharp,  as though  an 
all-or-none reaction  was  involved.  A  near-threshold  dose  sufficient  to  cause 
rolling in 1 mouse was almost always effective in all mice tested, while a slightly 
smaller amount failed to cause rolling in  any.  The point is illustrated  in the 
titration shown in Table I. 
TABLE I 
Titration of M. neurolyticum Toxin in M~e 
Dose of  Time of onset of rolling~  Time of deaths  Incidence of  toxin*  death§ 
rag 
10 
8 
6 
4 
2 
1 
mm 
5,  5,  10,  10,  30 
5,  5,  30,  30,  60 
20,  30,  30,  40,  60 
40,  60,  75,  90,  90 
40,  60,  90,  120, 120 
m 
mlm 
10,  10,  15,  60,  120 
20,  30,  60,  120,  120 
60,  90,  90,  120, 180 
120,  120, 180, 180, 180 
120,  120, 240, 240, 240 
S/S 
5/5 
5/5 
5/5 
5/5 
0/5 
* Lyoph~lized toxin from supernatant  broth, reconstituted in distilled water in a concen- 
tration of 20 mg per ml. 
Numbers refer to time after injection of toxin when individual mice were found rolling 
or dead. Absence of rolling disease indicated by -. 
§ Numerator: No. dead; denominator: No. injected. 
In general, mice which survived without symptoms for 3 hr after an injection 
of toxin remained entirely well. No instances of delayed or chronic disease were 
observed with doses less than the lethal ones; attempts to produce such disease 
by daily injections of sublethal doses were unsuccessful. 
Rats.pThe  latent interval between intravenous  injection and  the  onset of 
neurologic signs was similar to that in mice, but actual rolling was infrequently 
observed.  The  animals  usually  became  weak  and  prostrated,  made  grossly 
ataxic attempts at circling and leaping, then developed clonic convulsive move- 
ments of the extremities and became comatose. Death occurred in most cases 
3  to 4 hr after onset. The minimum lethal  dose  (M.L.D.) of  lyophilized  toxin 
was approximately the same as for mice, on a  body weight basis.  Prolonged 
survival with continuing neurologic signs occurred more frequently in rats, and 
a  group of animals surviving for 1 day or longer was obtained for some of the 
neuropathologic studies described below. 
Pathology of the Brain 
Focal lesions of spongiform degeneration,  with small cysflike cavities, were 
seen in the brains of mice and rats surviving for 8 hr or longer after intravenous 
toxin. The lesions were encountered in many regions of the cerebrum and cere- 1070  STUDIES  OF PPLO  INFECTION.  II 
bellum, but were most prominent in the deep layers of the frontoparietal cortex 
and  underlying white matter,  and in the molecular layer of the cerebellum. 
Cortex.--The lesions consisted of extensive, well demarcated areas of spongi- 
ness,  associated  with  the  accumulation of many vesicles, closely apposed  to 
each other and measuring 20 to 40 #  in diameter. Between the vesicles were 
thin, delicate septae in which glial nuclei were frequently found. The relation- 
ship of astrocytes to the accumulations of vesicles was a consistent one, and in 
some instances  these cells appeared to be the source of vacuolization. There 
was  no consistent relationship between capillaries  and vesicles, although oc- 
casionally large vacuoles surrounding a capillary were seen. 
Photographs illustrating the vesicular lesion are shown in Figs.  1 and 2. 
The meninges and superficial cortical layers were intact, and did not contain 
vesicles. The neurons appeared normal, and the Nissl substance was regularly 
distributed. There was some tortuosity of axones, with focal swelling and bal- 
looning revealed by Bielchowsky and Romanes stains, but their integrity was 
maintained. The microglia and other cells appeared normal. No vascular lesions 
or hemorrhages were seen. 
White Matter.--Vacuolization was observed within the white matter, but the 
areas were less clearly defined. When present, they were usually in immediate 
proximity to similar changes in the cortex and appeared to represent extensions 
of the same lesion. Damage to myelin sheaths in these areas was indicated by 
patchy zones of pallor in sections stained for myelin (Figs. 3 and 4). Sudano- 
philia was not demonstrable in these regions. No evidence of axonal degenera- 
tion was seen in association with the myelin damage. 
In rats and mice which survived for 2 days or longer after the onset of rolling, 
extensive lesions  of  necrosis  involving  all  tissue  elements  were  seen  in  the 
cerebral hemispheres and cerebellum (Fig. 5). These were bilateral and roughy 
symmetrical, resembling large areas of ischemic necrosis, with infiltration at 
the periphery by small numbers of mononuclear cells.  Here, as in the earlier, 
acute lesions, the blood vessels appeared intact. 
Sections of kidney, liver, lung, spleen, adrenal, and heart were normal in all 
animals examined, including several with severe brain lesions which survived 
for a period of 6 days. 
Electron Microscopy.--The areas in which vesicles were seen by light micros- 
copy were found to contain greatly distended astrocytes, with large quantities 
of intracellular fluid. The swollen cells were large enough to impinge on neigh- 
boring  structures,  causing  distortion and  compression of myelin sheaths.  A 
detailed account of the ultrastructural  changes  induced by M.  neurolyticum 
toxin is presented in a paper to follow (7). 
The neuropathologic observations suggest the possibility that the toxin acts 
primarily  on  the  membranes  of  astrocytes,  causing  damage  to  components 
which govern the permeability of this system of cells.  This possibility  will be THOMAS, ALEU, BITENSKY, DAVIDSON, AND  GESN'ER  1071 
raised again in a later section, in considering the in vitro binding  of toxin by a 
sedimentable component of brain. 
Effect of Toxin on the "Blood-brain Barrier" 
According to current views, the blood-brain barrier is, at least in part, de- 
pendent on the integrity of the astrocytes, since the brain contains virtually 
no extracellular fluid space (8). In view of the histologic evidence of increased 
permeability of these  cells  (7),  it was  of interest  to examine the passage  of 
inperitoneally injected trypan blue into the brains of mice treated with toxin. 
Three groups of 8 mice each were used. The first received intravenous toxin, 
in a dose sufficient to produce rolling with 1~/~ to 2 hr and death within 5 to 6 hr 
in all animals. The second received inactivated toxin, heated at 56°C for 30 min. 
The third received no intravenous injection. All were given 0.1  ml of 0.5% 
trypan  blue solution  in  saline  intraperitoneally just  before  the  injection of 
toxin, and  again at hourly intervals thereafter. The brains  of all mice in the 
group receiving toxin were removed immediately after death, and at the same 
time,  equal numbers of control mice from the groups receiving heated toxin 
and no injections were killed with ether and their brain removed. At the end 
of 5 hr, at which time there were 2 surviving mice in the toxin-injected group, 
both rolling and moribund, the experiment was terminated and all brains  re- 
moved. 
The brains  of all  toxin-injected mice were stained  with trypan blue,  with 
the exception of I mouse which died 15 rain after the injection of toxin. Some 
were  a  dusky  grey color, while  others  were deep blue.  None of the  control 
animals, given heat-inactivated toxin or no toxin, showed any trace of staining 
of the brain. 
Similar results were obtained with rats,  using intravenous toxin in  a  dose 
sufficient to cause severe neurological symptoms within 2 hr.  Four rats  were 
given 0.5 ml of 0.5 %  trypan blue intraperitoneally immediately before toxin, 
and  at hourly intervals thereafter. At the end of 6 hr,  all showed deep blue 
staining  throughout  the  cerebral hemispheres  (Fig.  6).  The  cerebellum  and 
brain stem were also stained, but with somewhat less intensity. Control rats, 
given heat-inactivated toxin and  trypan blue in the same  doses,  showed no 
staining of the brain. 
Properties of the Toxin 
The following experiments were performed with the same lot of lyophilized 
toxin,  stored  in  sealed  containers  at  --20°C.  The material  was  dissolved in 
distilled water in a  concentration of 20 mg per nil,  and the mice were given 
0.5 ml by tail vein; this amounted to 5 minimum lethal doses per mouse (see 
Table I). 
The toxin was completely inactivated by heating at 45°C for 15 mill, and by 1072  STUDIES  OF  PPLO  INFECTION.  II 
standing at 37°C for 2 hr. It was not affected by freezing at  -70°C,  nor by 
10 cycles of freezing and thawing at this temperature. It retained full activity 
after lyophilization when stored at --20°C for 4 months. 
Trypsin, in a  concentration of 0.025 mg per ml in the distilled water used 
for dissolving  the lyophilized toxin,  caused  complete inactivation within  10 
rain. The addition of crystalline soy bean inhibitor, in the same concentration, 
prevented inactivation by trypsin (Table II). 
The toxin was not sedimented by centrifugation at 140,000 g for 2 hr. It was 
not removed by pressure dialysis through a membrane admitting molecules of 
molecular weight less than 30,000. 
Samples of lyophilized toxin, reconstituted in distilled I-I~O, were placed in 
Sephadex G-200 columns, 45 cm in height, 2.5  cm in width, with resin volume 
TABLE  II 
Inactivation of Toxin by Trypsin 
Toxin treatment*  Incidence of death~ 
Toxin incubated with trypsin (0.025 mg/ml 10 rain) 
Toxin incubated with crystalline soy inhibitor (0.025 mg/ml) and 
trypsin 
Toxin incubated with soy inhibitor alone 
Toxin alone 
O/6 
6/6 
6/6 
6/6 
* Each sample of toxin incubated 10 rain at 37°C. 
As in Table I. 
of 200 ml, prepared with phosphate buffer 0.05 ~,  at pH 6.5. All of the toxin 
emerged in a  protein fraction immediately following the void volume eluate, 
in a  peak between 70 and 80 ml.  The finding indicates that the toxin has  a 
molecular weight in excess of 200,000, although the possibility cannot be ex- 
cluded that  it is  attached  to  a  protein constituent of this  molecular weight 
derived from the broth. 
Importance of Route of Injection.--The  toxin was only effective when injected 
intravenously.  Although  its  neurotoxic properties  indicate  an  action  on the 
central nervous system, it did not cause rolling or death when injected intra- 
cerebrally, even when an amount of toxin 20 times the minimum lethal dose 
was given. The same was true for the intraperitoneal and subcutaneous routes. 
The results, summarized in Table III, indicate that the toxin affects primarily 
the blood vessels of the brain, and is either bound or inactivated locally when 
injected by other routes. 
Protection by Antibody; Evidence  for Rapid Binding of Toxin 
Neutralization  of  the  toxin by rabbit  antibody against  the  A  strain  was 
demonstrated by mixing equal volumes  of  toxin  (containing  10  M.L.D.'S per THOMAS~ A.LEU~ BITENSKY,  DAVIDSON,  AND  GF.SNER  1073 
ml) with antiserum in various dilutions,  incubating the mixtures for 10 min at 
37°C,  and injecting in amounts of 0.5 ml per mouse. Antibody, in dilutions  as 
high  as  1  to 40,  furnished  complete protection.  No protection  was  observed 
TABLE IH 
Effect of Route of Injection on Letkal Action ~ ' Toxin 
Route of injection*  Dose of toxin  Incidence of death~ 
Intravenous 
Intracerebral 
Intraperitoneal 
Subcutaneous 
rag 
10 
2 
1 
40 
10 
40 
10 
40 
10 
6/6 
6/6 
0/6 
o/6 
O/6 
1/6 
0/6 
0/6 
0/6 
* Toxin injected in volume of 0.02 ml for intracerebral  injections, 0.5 ml for others. 
As in Table I. 
TABLE IV 
Protection of Mice Against Rolling Disease by Antibody 
Antibody*  Dilution  Timing  Incidence of  death 
Anti-A strain 
Anti-KSA strain 
Anti-M. orale 
Anti-M. gallisepticum 
Normal serum 
1-5 
1-20 
1-40 
1-80 
1-2 
1-2 
1-2 
1-2 
1-2 
1-2 
1-2 
1-2 
Before toxin 
ct  tc 
1 Min after toxin 
2 Min  "  " 
*c  *c  c* 
Before toxin 
c¢  cc 
¢,  cc 
o16 
o/6 
0/6 
6/6 
o/6 
o/6 
6/6 
6/6 
6/6 
6/6 
6/6 
6/6 
* Rabbit antisera used throughout,  in dose of 0.5 ml intravenously,  ~u dilutions indicated. 
with normal rabbit serum, nor with rabbit antiserum against Mycoplasma orale 
or Mycoplasma gallisepticum. 
Protection by antiserum in vivo was also demonstrable, but here the timing 
of the injection of antibody was of great importance. Table IV summarizes the 1074  STUDIES OF PPLO INFECTION. II 
results of an illustrative experiment. When given immediately before toxin, or 
within  1 or 2 min after, antiserum was  completely protective. But when de- 
layed for as short a time as 3 min after toxin, no protection was demonstrable. 
The control mice in this experiment did not begin to exhibit neurologic signs 
until 1 hr or longer after the injection of toxin, indicating that within the 2 min 
period in which antibody was protective the toxin was still available for neu- 
tralization,  but  after  this  time  the  material  became  bound  to  receptor 
sites inaccessible to antibody. Alternatively, the toxin may have accomplished 
irreversible injury within 3 min after injection. In either case, the results imply 
a high degree of affinity in vivo between the toxin and its target. 
It is of interest that antibody against the nontoxic strain of M. neurolyticum, 
the KSA strain,  failed to neutralize the toxin in vitro or in vivo (Table IV). 
This antiserum was indistinguishable from the anti-A antibody in its capacity 
to inhibit growth of the A strain on agar plates, suggesting that the toxin is 
immunologically distinct from the antigenic determinants involved in  growth 
inhibition. 
Inactivation of ttm Toxin by Brain Sedimentable Component 
The foregoing experiments suggested that rapid combination occurs in vivo 
between the toxin and a target receptor in the central nervous system. Accord- 
ingly, experiments were designed to learn whether binding of the toxin by brain 
tissue could be demonstrated in vitro. 
In a preliminary trial, various quantities of a crude 10 % saline homogenate 
of rat brain were added to a solution of lyophilized toxin, the mixtures incubated 
for 10 rain at 37°C, and then centrifuged at 13,000 g to remove the sedimentable 
brain fraction. It was found that 0.5 ml of toxin was completely inactivated by 
the addition of 0.025 ml of brain homogenate (Table V). 
The supernatant fraction of brain homogenate obtained by centrifugation at 
13,000 g for 30 min, had no inactivating effect on the toxin. The active material 
was most abundant in sedimentable fractious prepared by Aldridge's (9) modi- 
fication of the Hogeboom-Schneider (10)  technique  for the isolation of mito- 
chondria. An illustrative experiment follows: 
Two rat  brains,  weighing 3.5  g, were homogenized in 35  ml 0.3 ~  sucrose, 
using a  Potter homogenizer with a  Teflon pestle. The suspension was  centri- 
fuged at 1000 g for 10 min, and the supernatant fluid then centrifuged at 10,000 
g for 15 min. This sediment was taken up to the original volume in 0.3 ~ sucrose, 
homogenized again, and recentrifuged at 10,000 g/or 15 min. This process was 
repeated twice, and the final suspension then tested for its effect on toxin. To 
aliquots of 4  ml of toxin were added 0.8, 0.4, 0.2, and 0.1  amounts of brain 
suspension, the mixtures rotated in an incubator at 37°C for 10 min, and then 
centrifuged at 13,000 g for 15 min. The supernatant toxin samples were com- 
pared for activity with toxin to which the same volumes of 0.3 M sucrose were THOMAS~ ALEU,  BITENSKY,  DAVIDSON~ AND  GESNER  1075 
added,  with the same periods of incubation and rotation.  Six mice were tested 
with  each  sample,  in doses  of 0.5  ml each.  The  toxin  used  was  a  lyophilized 
stock  reconstituted in distilled water in a  concentration  of 50  mg per ml;  this 
preparation  contained  5  minimum  lethal  doses  in  0.5  ml.  To eliminate the 
TABLE V 
Inactivation of Toxin by Brain Extracts 
Tissue extract* 
Brain, 1000 g, supemate 
Brain, 10,000 g sediment, (resuspended as 10% 
suspension) 
Brain, 10,000 g supernatant 
Brain, 10,000 g sediment, treated with 
0.0005 M K periodate 
Brain, 10,000 g sediment, heated 80°C 30 rain 
Brain, 10,000 g sediment, treated with trypsin 
Amount of brain 
extract added  to 
0.5 ml toxin~: 
0.1  ml 
0.05  " 
0.025  " 
0.01  " 
0.1  ¢~ 
0.05  " 
0.025  " 
0.01  " 
0.1 
0.05 
0.1 
0.05 
0.05 
0.025  " 
0.01  " 
0.05  " 
0.025  " 
0.01  " 
Incidence 
death 
0/6 
o/6 
0/6 
6/6 
0/6 
0/6 
0/6 
6/6 
"  6/6 
"  6/6 
"  6/6 
"  6/6 
"  0/6 
0/6 
6/6 
o/6 
0/6 
6/6 
Brain ganglioside  0.25 mg  0/6 
Liver, 10,000 g sediment 
Kidney, 10,000 g sediment 
0.1  ml 
0.05  " 
0.1  ¢c 
0.05  " 
0.1  ¢¢ 
0.05  " 
6/6 
6/6 
4/6 
6/6 
6/6 
6/6 
Kidney, 10,000 g sediment, heated 70°C 30 rain 
of  Protection 
by extract 
+ 
+ 
+ 
0 
+ 
+ 
+ 
0 
0 
0 
0 
0 
+ 
+ 
0 
+ 
+ 
0 
+ 
0 
0 
-t- 
O 
0 
0 
* All tissues derived from rat except for ganglioside, which was prepared from beef brain. 
Each mixture of tissue extract and toxin incubated 37°C 10 min before injection into 
mice. Toxin dose per mouse ffi 0.5 ml, containing 5 Xr.L.V.'S. 1076  STIYDIES O~ PPLO  INFECTION. II 
possibil{ty of  lethal  reactions  to  residual  thromboplastic  material  following 
exposure of toxin to brain sediment, heparin was added to all preparations of 
toxin in a concentration of 0.05 mg per rul (11). By itself, heparin had no effect 
on the activity of the toxin. 
The results are shown in Table V. The sedimentable brain fraction caused 
complete inactivation when amounts as low as 0.025 ml were combined with 
0.5  ml  toxin.  No  inactivation  occurred with  the  supernatant  brain  extract 
obtained by centrifugation at 10,000 g. 
No  toxin was  demonstrable  in  the  brain  sediments  after incubation with 
toxin,  when these  were resuspended  in  Ringer's  solution containing heparin 
and injected into mice. It thus appears that if the inactivation of toxin by the 
brain component involves adsorption of the toxin, the process is not reversible. 
The factor responsible for inactivation of toxin was remarkably thermostable, 
withstanding heating at 80°C for 1 hr. It was not affected by treatment with 
trypsin. Exposure of the washed brain sediment to 0.0005 ~  K  periodate for 
10 rain at 37°C resulted in complete loss of activity. These properties are sum- 
marized  in Table V.  The material remained  active after lyophilization,  and 
could be stored as dry powder for several weeks without change in activity. 
However, it was observed on several occasions that suspensions of the fraction 
in saline or Ringer's solution lost their inactivating property after incubation 
at 37°C for 1 hr. The possibility that enzymes may be present in these prepara- 
tions which are capable of destroying the inactivating factor is currently under 
study. 
The sedimentable component of rat liver, prepared in the same manner, had 
no inactivating effect on toxin. Relatively slight and inconstant inactivation 
was  observed  with  suspensions  of  rat  lung  and kidney sediment,  but  the 
property disappeared when these suspensions were heated at 70°C for 30 rain. 
Inactivation by Ganglioside.--The thermostability of the inactivating factor, 
and  the  loss  of  its  effect following treatment  with periodate,  suggested  the 
possibility that a  carbohydrate fraction of brain sediment might be involved. 
Van Iteyningen and his associates have described the selective inactivation of 
tetanus toxin by gangliosides derived from brain (12), and four different prep- 
arations of ganglioslde were therefore tested for their effect on M. neurolyticurn 
toxin.  Three of these were purified ganglioside derived from beef brain;  the 
fourth  was  a  monosialic  ganglioside  from  a  human  brain  with  Tay-Sachs 
disease}  All  caused  inactivation  of  toxin  when  added  in  concentrations  of 
0.5 mg per ml and incubated for 10 rain at 37°C  (Table V). It is of interest 
that  the inactivation by ganglioside  and  by the washed,  sedimentable  com- 
ponent of rat brain were both temperature-dependent (Table VI).  Each was 
1  The authors are indebted to Dr. Irwin Chargaff, Dr. Alan Bemheimer, and Dr. Herbert 
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effective at 37°C, while neither caused inactivation when held with toxin for 
1 hr at 0°C. 
It is possible that the active  material in the sedimentable fraction of rat 
brain may be its ganglioside, but the point remains speculative at present. On a 
weight basis,  purified ganglioside is  more  active than the  lyophilized brain 
fraction (0.5 mg as compared with 3 nag per ml), but the difference is less than 
might be expected if the effect of the brain fraction were entirely due to its 
content of ganglioside. In this connection, however, it should be noted that 
Van Heyningen found that the activity of water-soluble gangiioside in binding 
tetanus toxin was considerably less than that of ganglioside contained in water- 
insoluble ganglioside-cerebroside-calcium complexes (12). 
TABLE VI 
Temperature Dependence of Inactivat~ra of Toxin by Brain Extract 
Brain extract  Temperature  Incidence of  Protection  death 
12,000 g sediment, 0.05 ml in 0.5 ml toxin 
Ganglioside, 0.25 mg in 0.5 ml toxin 
og 
37 10 rain 
o  lhr 
37 lO rain 
o  lhr 
o/6 
6/6 
0/6 
6/6 
+ 
0 
+ 
0 
DISCUSSION 
The following theoretical concept of the mode of action of the  exotoxin of 
M. neurolyticum is proposed. The material possesses  a high degree of affinity 
for membrane receptors within the central nervous system, perhaps located in 
the podocytes of glial cells at their sites of attachment in the capillaries. Inter- 
action between toxin and receptor results in disruption of the normal membrane 
regulation of fluid transport, and the astrocytes become greatly distended by 
imbibed fluid. The generalized swelling of the brain, as well as local compression 
of nerve cells  and axones by individual astrocytes, are considered to account 
for the neurological manifestations and death of the animals. 
The evidence for increased permeability of cells throughout the brain derives 
in part from the vesicular lesions seen by light microscopy, but primarily from 
the  observed  changes  in  electron microscopic sections described  in  a  paper 
which follows (7).  Swelling of glial cells, distended with fluid to such an extent 
that physical damage to neighboring cells  and fibers occurred, was regularly 
encountered in all regions of the brain in both rats and mice. It is, of course, 
possible that the phenomenon of rolling may itself be due to some earlier, more 
primary event; it is conceivable that leakage of substances from the affected 1078  STUDIES OF PPLO  INFECTION.  II 
cells may be the cause of conduction disturbances leading to rolling. However, 
the subsequent,  widely disseminated lesions of necrosis  in the cerebral hemi- 
spheres and cerebeUum seem almost certainly to be based on this initial reaction 
of glial swelling. 
The experiments with trypan blue provide further evidence for a generalized 
disruption of the blood brain barrier, associated with the onset of rolling disease. 
The deep staining of rat and mouse brains, which occurred when trypan blue 
was  injected intraperitoneally after toxin,  may be  a  direct result of the  in- 
creased flow of fluid into the astrocytes, or leakage into the extracellular space 
of the brain. There is little evidence of an extracellular space in normal brain, 
but an artificial space may be created in these animals by disruption of swollen 
glial cells. 
In view of its thermolability, large molecular size, and inactivation by tr~psin, 
the  toxin  is  probably a  protein molecule. Whether  or  not  other  nonprotein 
moieties  contribute  to  its  biological  properties  cannot  be  determined  until 
more highly purified preparations are obtained. 
Although the toxin obviously acts primarily on the central nervous system, 
and perhaps solely here since no lesions  in other organs can be demonstrated, 
it is of interest that it has no effect when injected directly into the brain. The 
observation suggests that the neural target for the toxin is only accessible  by 
way of the  lumen of the  capillaries  of the brain.  Failure  of  intracerebrally 
injected toxin, as well as toxin given by subcutaneous or intraperitoneal routes 
to cause rolling disease, even with large doses,  may perhaps be explained by 
local binding or inactivation by components of the tissue. 
The rapidity with which the toxin becomes attached to its receptor in the 
living animal is indicated by the experiments dealing with protection by rabbit 
antibody. Complete protection was provided by antibody given by vein just 
before the toxin, or within 2 min after, but when the antibody was delayed 
until 3 min, protection was lost. It is important to note that both the control 
and antibody-injected animals in this experiment had a  symptom-free latent 
period of at least 1 hr before the onset of rolling. The results suggest that the 
toxin becomes fully attached within less than 3 min after injection, and then is 
inaccessible to antibody. 
The rapid inactivation of the toxin by exposure to suspensions of the sedi- 
mentable component of brain tissue suggests an analogy to the situation de- 
scribed by Van Heyningen with tetanus toxin (12).  An important difference, 
however, is that the neurolyticum toxin becomes completely and irreversibly 
inactivated, while tetanus toxin retains its activity after adsorption to brain 
suspensions.  As  was  reported  for  tetanus  toxin,  solutions  of  water-soluble 
ganglioside inactivate M. neurolyticum  toxin. The inactivation of the toxin by 
both ganglioside and crude brain suspensions occurs within a few minutes at 
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ponent  of  the  crude  suspension,  and  perhaps  also  the  receptor  for  M. 
neurolyticum toxin in the living  animal brain; conceivably, ganglioside may be 
a substrate for enzymatic action by the toxin.  The information available at this 
time cannot settle the point. 
If ganglioside  should prove to be a specific, selective receptor for M. neuro- 
lyticum  toxin,  a new line  of investigation may be opened for common ground 
between this and another,  unrelated mycoplasma with neurotoxic properties. 
M. gallisepticum  (the  S-6  strain)  produces  acute neurological  manifestations 
and death within a few hours in turkey poults (as well as cerebral polyarteritis 
in birds surviving for 2 days or longer)  (13). This mycoplasma was shown to 
adhere to the surface of turkey erythrocytes by binding to a sialic acid receptor 
at the cell surface (14). It is conceivable that the sialic acid groups of ganglio- 
sides may also be concerned in the binding and inactivation of the toxin of M. 
neurolyticura. Further work on the possibility is in progress. 
SII~RY 
Rolling disease has been produced and studied in rats and mice,  using  the 
exotoxin of the A strain of Mycoplasma neurolyticum. 
The  primary  lesion  of the  brain  consists  of spongiform degeneration,  as- 
sociated with vesicle formation in the cortex and underlying white matter of the 
cerebral hemispheres,  and in the molecular layer of the cerebellum. The brains 
of animals surviving 2 days or longer  show extensive necrotizing  lesions resem- 
bling ischemic necrosis, in both cerebral hemispheres. 
The brains of rats and mice with rolling  disease become deeply stained by 
intraperitoneally injected trypan blue, indicating early disruption of the blood 
brain barrier. 
The  toxin  appears  to be a  thermolabile  protein  with  a  molecular  weight 
exceeding  200,000. It  is  only active  when  injected  by vein,  and  causes  no 
disease  when  injected  intracerebraUy,  intraperitoneally  or  subcutaneously, 
suggesting the  existence  of specific  receptors within  the vascular bed of the 
central nervous system. 
Protection is afforded by rabbit antibody against the toxin,  but only when 
antibody is injected within less than 3 min after intravenous injection of toxin, 
indicating rapid fixation to receptors in the brain. 
The toxin is inactivated by incubation for 10 rain at 37°C with suspensions 
of the sedimentable component of normal brain. The inactivating factor in brain 
sediment  is  very thermostable,  not  affected by trypsin,  and  eliminated  by 
treatment  with periodate.  Similar  inactivation of toxin is demonstrable with 
water-soluble gangliosides of brain. 
A theoretical concept to explain the action of the toxin is proposed. 
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FIG.  1. Hematoxylin and eosin-stained section of  rat  brain illustrating areas of 
vacuolization in deep cortex and superficial white matter. Most of  the vacuoles are 
closely related to astrocytes.  The white matter is pale and has a  loose appearance. 
There is no evidence of inflammation. 20 hr lesion. ×  37 
FIG. 2.  Hematoxylin and eosin-stained  sectionilinstrating  another area of vacuoliza- 
tion similar to that shown in Fig. 1.20 hr lesion. ×  37 
FIG. 3.  Luxol-fast blue with PAS counterstain to demonstrate focal areas of myelin 
loss in the superficial white matter. 20 hr lesion.  ×  37 
FIG. 4.  Bielchowsky preparation from the same region as Fig. 3, illustrating a loose 
axonal arrangement. 20 hr lesion.  X 37 
FIG. 5.  2-day-old lesion. Parenchymal destruction of cerebellum associated  with a 
moderate inflammatory cell infiltrate. X  37 
FIG. 6.  Brains from rats given intraperitoneal injections  of trypan blue. The blue 
brain is from a  rat which died 6 hr after an intravenous injection of toxin. The un- 
stained brain is from a control rat given heat-inactivated toxin. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  124  PLATE  100 
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